Lonza buys Arch Chemicals for $1.2 billion

July 12, 2011
Manufacturing and Production Lonza, pharma manufacturing news

Swiss fine chemical and contract manufacturing company Lonza has agreed to buy Arch Chemicals of the USA for $1.2 billion …

Takeda forced to withdraw Actos in France

July 11, 2011
Sales and Marketing Actos, Competact, Takeda, diabetes

Takeda has officially taken its diabetes drug Actos off the market in France at the request of the country’s medicines …

Cadila plant in India gets FDA warning

July 11, 2011
Manufacturing and Production Cadila, FDA warning letter, pharma manufacturing news

Indian drugmaker Cadila Healthcare has been taken to task by the US FDA for quality violations at a new sterile …

Pfizer’s ageing blockbuster Lipitor wins $770m paediatric boost

July 11, 2011
Sales and Marketing Lipitor, Pfizer, paediatric trials

Pfizer has been given more time to sell its anti-cholesterol treatment Lipitor exclusively in Europe as a quid pro quo …

Sanofi

Sanofi sells dermatology unit for $425m

July 11, 2011
Manufacturing and Production, Sales and Marketing Canada, Dermik, Sanofi, Valeant, dermatology

Sanofi has sold its Canadian dermatology unit Dermik for $425 million in order to concentrate on key growth areas like …

idea_pharma_louisa_roberts

Lousia Roberts and Ralph Torbay join Idea Pharma

July 11, 2011
Sales and Marketing appointment, sales and marketing

Idea Pharma has two new additions to its team, appointing Louisa Roberts and Ralph Torbay. Louise joins the phase II …

Novartis’ Votubia reduces benign brain tumours in SEGA patients

July 11, 2011
Research and Development Novartis, SEGA, Votubia, everolimus

Novartis’ novel cancer drug Votubia has reduced the size of SEGA brain tumours in a late-stage trial. Votubia (or everolimus …

Kantar Health Names Werner Guminski CEO, Commercial Strategy

July 8, 2011
Business Services, Research and Development Kantar Health, commercial strategy

Kantar Health Names Werner Guminski CEO, Commercial StrategyNEW YORK, July 8, 2011—Kantar Health, a leading healthcare-focused global consultancy and marketing …

Publicis Life Brands Resolute boosts team

July 8, 2011
Medical Communications appointment, medical communications, medical communications news, publicis

London-based healthcare communications agency Publicis Life Brands Resolute has boosted its Creative and Digital division with four new appointments. They …

Ferring relocates to new UK headquarters

July 8, 2011
Sales and Marketing Ferring, UK pharma

Ferring Pharmaceuticals has moved its UK operations from Slough to new facilities just outside London in West Drayton. The Swiss …

Lilly chief: German reforms jeopardise pharma innovation

July 8, 2011
Research and Development, Sales and Marketing Germany, John Lechleiter, lilly, medicines pricing

German healthcare spending cuts have gone too far and risk jeopardising pharmaceutical innovation in the country, according to Lilly’s chief …

Pfizer sharpens its pharma focus

July 8, 2011
Sales and Marketing Pfizer, animal health, nutrition, pharma strategy

Pfizer has given its strongest signal yet that its animal health and nutrition arms do not have long to last …

Eurocom wins healthcare services account

July 7, 2011
Medical Communications Eurocom, medical communications agency, medical communications news

Eurocom Healthcare Communications has been appointed to develop a strategic marketing communications programme for a UK healthcare services company. Malling …

Sanofi's Neale Harris

Working Life: Sanofi’s oncology franchise director

July 7, 2011
Business Services, Sales and Marketing Working Life, careers, recruitment

Sanofi’s oncology franchise director Neale Harris talks to Pharmafocus about how his field is changing and offers some advice for …

Working through the ‘ZOUD’

July 7, 2011
Business Services, Research and Development, Sales and Marketing careers, management, recruitment

Most senior managers find their executive team difficult. ‘Dysfunctional’ is a favourite word. Testing dynamics, political agendas, big personalities, strong …

BMS licences potential first-in-class cancer biologic

July 7, 2011
Research and Development BMS, Cancer, biologics

Bristol-Myers Squibb has signed a $465 million deal for the rights to a potential first-in-class treatment for cancer. IPH2102 is …

Former Sanofi-Pasteur MSD president joins board at Genticel

July 6, 2011
Research and Development appointment, research and development

Genticel has named Dr Didier Hoch, former president of Sanofi-Pasteur MSD, to its supervisory board as conseil de surveillance.Dr Hoch …

Sanofi

Sanofi launches Jevtana in UK

July 6, 2011
Sales and Marketing Jevtana, Sanofi, prostate cancer

Sanofi has launched its promising advanced prostate cancer drug Jevtana in the UK following EMA approval in March. Jevtana (cabazitaxel) …

GlaxoSmithKline

GSK changes the way its US sales reps are assessed

July 6, 2011
Sales and Marketing GSK, pharma sales force

GlaxoSmithKline has revealed a new way of assessing its US sales representatives’ performance in a bid to make the manufacturer’s …

The Gateway to Local Adoption Series

Latest content